WRAP73
gene geneOn this page
Summary
WRAP73 (WD repeat containing, antisense to TP73, HGNC:12759) is a protein-coding gene on chromosome 1p36.32, encoding WD repeat-containing protein WRAP73 (Q9P2S5). The SSX2IP:WRAP73 complex is proposed to act as regulator of spindle anchoring at the mitotic centrosome.
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. Studies of the related mouse protein suggest that the encoded protein may play a role in the process of ossification.
Source: NCBI Gene 49856 — RefSeq curated summary.
At a glance
- Gene–disease (curated): anterior segment dysgenesis (Moderate, GenCC)
- Clinical variants (ClinVar): 114 total
- MANE Select transcript:
NM_017818
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12759 |
| Approved symbol | WRAP73 |
| Name | WD repeat containing, antisense to TP73 |
| Location | 1p36.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000116213 |
| Ensembl biotype | protein_coding |
| OMIM | 606040 |
| Entrez | 49856 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 16 protein_coding, 5 retained_intron
ENST00000270708, ENST00000378322, ENST00000419924, ENST00000424367, ENST00000465916, ENST00000469643, ENST00000471223, ENST00000479331, ENST00000494884, ENST00000497940, ENST00000855126, ENST00000855127, ENST00000855128, ENST00000855129, ENST00000855130, ENST00000920579, ENST00000920580, ENST00000920581, ENST00000960492, ENST00000960493, ENST00000960494
RefSeq mRNA: 1 — MANE Select: NM_017818
NM_017818
CCDS: CCDS48
Canonical transcript exons
ENST00000270708 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000734299 | 3646666 | 3646782 |
| ENSE00000734303 | 3638750 | 3638822 |
| ENSE00000734306 | 3636995 | 3637098 |
| ENSE00001659258 | 3633398 | 3633503 |
| ENSE00001697450 | 3630770 | 3631117 |
| ENSE00001748742 | 3649931 | 3650103 |
| ENSE00001797222 | 3631466 | 3631657 |
| ENSE00003480267 | 3635944 | 3636030 |
| ENSE00003492457 | 3635160 | 3635294 |
| ENSE00003566716 | 3647408 | 3647560 |
| ENSE00003685083 | 3634997 | 3635074 |
| ENSE00003789737 | 3632213 | 3632338 |
Expression profiles
Bgee: expression breadth ubiquitous, 259 present calls, max score 91.29.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.1278 / max 63.7689, expressed in 1779 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9951 | 7.6761 | 1762 |
| 9950 | 1.4517 | 792 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 91.29 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.65 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.13 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 88.52 | gold quality |
| cerebellar cortex | UBERON:0002129 | 88.38 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.65 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 87.59 | gold quality |
| spleen | UBERON:0002106 | 87.11 | gold quality |
| adenohypophysis | UBERON:0002196 | 87.02 | gold quality |
| apex of heart | UBERON:0002098 | 86.98 | gold quality |
| blood | UBERON:0000178 | 86.80 | gold quality |
| cerebellum | UBERON:0002037 | 86.77 | gold quality |
| monocyte | CL:0000576 | 86.68 | gold quality |
| body of stomach | UBERON:0001161 | 86.66 | gold quality |
| oocyte | CL:0000023 | 86.39 | gold quality |
| leukocyte | CL:0000738 | 86.35 | gold quality |
| mononuclear cell | CL:0000842 | 86.27 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.17 | gold quality |
| body of pancreas | UBERON:0001150 | 85.73 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.70 | gold quality |
| pituitary gland | UBERON:0000007 | 85.64 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 85.58 | gold quality |
| lower esophagus | UBERON:0013473 | 85.57 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 85.57 | gold quality |
| transverse colon | UBERON:0001157 | 85.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.45 | gold quality |
| small intestine | UBERON:0002108 | 85.35 | gold quality |
| right ovary | UBERON:0002118 | 85.33 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 85.27 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.81 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1
miRNA regulators (miRDB)
17 targeting WRAP73, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-4705 | 99.10 | 69.10 | 1091 |
| HSA-MIR-6779-3P | 97.51 | 65.82 | 789 |
| HSA-MIR-34A-3P | 96.80 | 67.70 | 805 |
Literature-anchored findings (GeneRIF, showing 4)
- Knockdown of Wdr8 or hMsd1/SSX2IP displayed very similar mitotic defects, in which spindle microtubules became shortened and misoriented. (PMID:26545777)
- Cep135 is required for the recruitment of WDR8 to centrioles. (PMID:26675238)
- Exome sequencing and functional studies in zebrafish identify WDR8 as the causative gene for isolated Microspherophakia in Indian families. (PMID:33693649)
- Mitotic Maturation Compensates for Premature Centrosome Splitting and PCM Loss in Human cep135 Knockout Cells. (PMID:35406752)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wrap73 | ENSDARG00000009557 |
| mus_musculus | Wrap73 | ENSMUSG00000029029 |
| rattus_norvegicus | Wrap73 | ENSRNOG00000014805 |
Protein
Protein identifiers
WD repeat-containing protein WRAP73 — Q9P2S5 (reviewed: Q9P2S5)
Alternative names: WD repeat-containing protein 8, WD repeat-containing protein antisense to TP73 gene
All UniProt accessions (6): Q9P2S5, A0A0A0MRV3, A0A384MQZ3, J3KTP2, Q5T0D5, Q5TBW1
UniProt curated annotations — full annotation on UniProt →
Function. The SSX2IP:WRAP73 complex is proposed to act as regulator of spindle anchoring at the mitotic centrosome. Required for the centrosomal localization of SSX2IP and normal mitotic bipolar spindle morphology. Required for the targeting of centriole satellite proteins to centrosomes such as of PCM1, SSX2IP, CEP290 and PIBF1/CEP90. Required for ciliogenesis and involved in the removal of the CEP97:CCP110 complex from the mother centriole. Involved in ciliary vesicle formation at the mother centriole and required for the docking of vesicles to the basal body during ciliogenesis; may promote docking of RAB8A- and ARL13B-containing vesicles.
Subunit / interactions. Interacts with SSX2IP.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriole. Centriolar satellite.
Tissue specificity. Ubiquitous. Predominant expression in heart, brain, liver, thymus, prostate, and testis, and barely detectable expression in lung.
RefSeq proteins (1): NP_060288* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR052778 | Centrosome-WD_assoc | Family |
Pfam: PF00400
UniProt features (12 total): repeat 6, sequence conflict 2, sequence variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P2S5-F1 | 90.26 | 0.84 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 281
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 138 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, MULLIGHAN_NPM1_SIGNATURE_3_UP, BENPORATH_ES_WITH_H3K27ME3, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, MUELLER_PLURINET, GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_MITOTIC_SPINDLE_ASSEMBLY, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_ORGANELLE_FISSION, MARTINEZ_RB1_TARGETS_DN, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME
GO Biological Process (4): cell projection organization (GO:0030030), mitotic spindle assembly (GO:0090307), positive regulation of non-motile cilium assembly (GO:1902857), microtubule anchoring at mitotic spindle pole body (GO:1990810)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): cytoplasm (GO:0005737), centrosome (GO:0005813), centriole (GO:0005814), microtubule organizing center (GO:0005815), centriolar satellite (GO:0034451), ciliary basal body (GO:0036064), MWP complex (GO:1990811), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| microtubule organizing center | 3 |
| intracellular membraneless organelle | 2 |
| cellular component organization | 1 |
| mitotic sister chromatid segregation | 1 |
| mitotic spindle organization | 1 |
| spindle assembly | 1 |
| mitotic nuclear division | 1 |
| positive regulation of cilium assembly | 1 |
| regulation of non-motile cilium assembly | 1 |
| non-motile cilium assembly | 1 |
| microtubule anchoring at spindle pole body | 1 |
| mitotic spindle assembly | 1 |
| microtubule cytoskeleton organization involved in mitosis | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| centriole | 1 |
| microtubule cytoskeleton | 1 |
| centrosome | 1 |
| cilium | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
940 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WRAP73 | MEGF6 | O75095 | 877 |
| WRAP73 | ZBTB40 | Q9NUA8 | 826 |
| WRAP73 | SSX2IP | Q9Y2D8 | 648 |
| WRAP73 | CD3D | P04234 | 633 |
| WRAP73 | DNAJC7 | Q99615 | 547 |
| WRAP73 | TPRG1L | Q5T0D9 | 541 |
| WRAP73 | NEDD1 | Q8NHV4 | 531 |
| WRAP73 | PUM2 | Q8TB72 | 497 |
| WRAP73 | TNFRSF1B | P20333 | 496 |
| WRAP73 | WDR81 | Q562E7 | 484 |
| WRAP73 | CELF1 | Q92879 | 481 |
| WRAP73 | KIFC1 | Q9BW19 | 476 |
| WRAP73 | DDX51 | Q8N8A6 | 471 |
| WRAP73 | PUM1 | Q14671 | 468 |
| WRAP73 | TUBGCP2 | Q9BSJ2 | 467 |
IntAct
143 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:2364”(proximity) | 0.900 |
| WRAP73 | CEP135 | psi-mi:“MI:0914”(association) | 0.890 |
| CEP290 | CCP110 | psi-mi:“MI:2364”(proximity) | 0.890 |
| WRAP73 | SSX2IP | psi-mi:“MI:0915”(physical association) | 0.860 |
| WRAP73 | SSX2IP | psi-mi:“MI:0403”(colocalization) | 0.860 |
| SSX2IP | WRAP73 | psi-mi:“MI:0915”(physical association) | 0.860 |
| OSBPL9 | VAPB | psi-mi:“MI:0914”(association) | 0.790 |
| WRAP73 | Cep135 | psi-mi:“MI:0403”(colocalization) | 0.700 |
| ENTREP1 | NEDD4 | psi-mi:“MI:0914”(association) | 0.690 |
| WRAP73 | NUDC | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP135 | SPICE1 | psi-mi:“MI:0914”(association) | 0.540 |
| WRAP73 | Ssx2ip | psi-mi:“MI:0915”(physical association) | 0.540 |
| WRAP73 | Ssx2ip | psi-mi:“MI:0403”(colocalization) | 0.540 |
| DNAJA1 | DNAJA2 | psi-mi:“MI:0914”(association) | 0.530 |
| KIAA0753 | OFD1 | psi-mi:“MI:2364”(proximity) | 0.480 |
| SSX2IP | SPICE1 | psi-mi:“MI:0914”(association) | 0.420 |
| AHI1 | OFD1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| WRAP73 | cep135 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Cep135 | CEP135 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Cep135 | psi-mi:“MI:0914”(association) | 0.350 | |
| OFD1 | CCDC14 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP135 | TBC1D31 | psi-mi:“MI:0914”(association) | 0.350 |
| PCM1 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| CEP162 | IPO5 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP135 | AIMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| SSX2IP | IPO7 | psi-mi:“MI:0914”(association) | 0.350 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| WRAP73 | AKAP8 | psi-mi:“MI:0914”(association) | 0.350 |
| WRAP73 | Fmnl2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (183): WRAP73 (Affinity Capture-MS), WRAP73 (Affinity Capture-MS), WRAP73 (Affinity Capture-MS), SPEN (Affinity Capture-MS), QRICH1 (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), TNKS1BP1 (Affinity Capture-MS), RBM12 (Affinity Capture-MS), CEP135 (Affinity Capture-MS), SSSCA1 (Affinity Capture-MS), HDDC3 (Affinity Capture-MS), SDCBP (Affinity Capture-MS), DNAJB4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), RNF219 (Affinity Capture-MS)
ESM2 similar proteins: A0A4X1TB62, A5D7H2, A7MB16, F1Q8X5, O14562, O35841, O42611, P0C606, P23116, P54198, P55884, P58405, P79987, Q13033, Q13112, Q14152, Q15542, Q1JU68, Q4G061, Q569Z1, Q5E9L7, Q5KU39, Q5R644, Q5R660, Q5R7U7, Q61666, Q676U5, Q6NYU2, Q6PCR7, Q8BHL5, Q8C092, Q8CBY8, Q8JZQ9, Q8QFR2, Q8VHE0, Q91W86, Q96ES7, Q96KG9, Q9BZZ5, Q9D0N7
Diamond homologs: Q9JM98, Q9P2S5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 147 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | 10 | 16.0× | 8e-08 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 10 | 16.0× | 8e-08 |
| AURKA Activation by TPX2 | 10 | 15.4× | 8e-08 |
| Anchoring of the basal body to the plasma membrane | 13 | 14.8× | 2e-09 |
| Degradation of DVL | 6 | 14.4× | 2e-04 |
| DNA Damage Recognition in GG-NER | 5 | 14.4× | 1e-03 |
| Regulation of PLK1 Activity at G2/M Transition | 11 | 14.1× | 8e-08 |
| Recruitment of mitotic centrosome proteins and complexes | 10 | 13.7× | 2e-07 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| centriole replication | 7 | 39.8× | 1e-07 |
| protein folding | 11 | 8.8× | 1e-05 |
| cilium assembly | 15 | 8.6× | 1e-07 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 10 | 4.0× | 8e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
114 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 93 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2201 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:3631460:GCTTA:G | donor_loss | 1.0000 |
| 1:3631461:CTTA:C | donor_loss | 1.0000 |
| 1:3631462:TTA:T | donor_loss | 1.0000 |
| 1:3631463:TA:T | donor_loss | 1.0000 |
| 1:3631464:A:AT | donor_loss | 1.0000 |
| 1:3632630:G:C | donor_gain | 1.0000 |
| 1:3633394:TTAC:T | donor_loss | 1.0000 |
| 1:3633396:A:AC | donor_gain | 1.0000 |
| 1:3633396:A:T | donor_loss | 1.0000 |
| 1:3633397:C:CT | donor_gain | 1.0000 |
| 1:3633397:CA:C | donor_gain | 1.0000 |
| 1:3634993:TTA:T | donor_loss | 1.0000 |
| 1:3634994:TA:T | donor_loss | 1.0000 |
| 1:3634995:A:AC | donor_gain | 1.0000 |
| 1:3634995:ACTAT:A | donor_gain | 1.0000 |
| 1:3634996:C:A | donor_loss | 1.0000 |
| 1:3634996:C:CC | donor_gain | 1.0000 |
| 1:3634996:CT:C | donor_gain | 1.0000 |
| 1:3634996:CTA:C | donor_gain | 1.0000 |
| 1:3634996:CTAT:C | donor_gain | 1.0000 |
| 1:3634996:CTATC:C | donor_gain | 1.0000 |
| 1:3635073:ACCT:A | acceptor_loss | 1.0000 |
| 1:3635075:C:CA | acceptor_loss | 1.0000 |
| 1:3635076:T:G | acceptor_loss | 1.0000 |
| 1:3635163:T:A | donor_gain | 1.0000 |
| 1:3636989:CCTTA:C | donor_loss | 1.0000 |
| 1:3636990:CTTA:C | donor_loss | 1.0000 |
| 1:3636991:TTA:T | donor_loss | 1.0000 |
| 1:3636992:TACC:T | donor_loss | 1.0000 |
| 1:3636993:A:AT | donor_loss | 1.0000 |
AlphaMissense
2994 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:3631565:A:G | W381R | 0.999 |
| 1:3631565:A:T | W381R | 0.999 |
| 1:3638807:A:G | W119R | 0.999 |
| 1:3638807:A:T | W119R | 0.999 |
| 1:3638809:A:T | V118D | 0.999 |
| 1:3646710:A:G | W99R | 0.999 |
| 1:3646710:A:T | W99R | 0.999 |
| 1:3647464:A:G | W56R | 0.999 |
| 1:3647464:A:T | W56R | 0.999 |
| 1:3635207:A:G | W231R | 0.998 |
| 1:3635207:A:T | W231R | 0.998 |
| 1:3637039:C:G | D158H | 0.998 |
| 1:3631508:A:G | W400R | 0.997 |
| 1:3631508:A:T | W400R | 0.997 |
| 1:3635991:A:G | W186R | 0.997 |
| 1:3635991:A:T | W186R | 0.997 |
| 1:3646685:A:G | L107P | 0.997 |
| 1:3646705:G:C | S100R | 0.997 |
| 1:3646705:G:T | S100R | 0.997 |
| 1:3646707:T:G | S100R | 0.997 |
| 1:3646745:A:T | I87K | 0.997 |
| 1:3646781:A:T | V75D | 0.997 |
| 1:3647529:C:G | R34P | 0.997 |
| 1:3635172:G:C | S242R | 0.996 |
| 1:3635172:G:T | S242R | 0.996 |
| 1:3635174:T:G | S242R | 0.996 |
| 1:3637053:C:G | R153P | 0.996 |
| 1:3638804:A:G | S120P | 0.996 |
| 1:3638818:C:G | R115P | 0.996 |
| 1:3646745:A:C | I87R | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000131167 (1:3633905 C>T), RS1000133295 (1:3638839 G>A,C), RS1000208317 (1:3634100 C>A), RS1000228376 (1:3635517 C>T), RS1000239551 (1:3641081 A>C,G,T), RS1000246665 (1:3650189 T>A,C,G), RS1000484213 (1:3639022 T>C), RS1000689840 (1:3640780 C>T), RS1000842452 (1:3649020 A>G), RS1000942548 (1:3642418 T>C), RS1000979190 (1:3646829 C>A), RS1001055339 (1:3642781 G>T), RS1001170028 (1:3648733 C>T), RS1001240631 (1:3642316 A>G), RS1001468655 (1:3631878 C>G,T)
Disease associations
OMIM: gene MIM:606040 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| anterior segment dysgenesis | Moderate | Autosomal recessive |
Mondo (1): anterior segment dysgenesis (MONDO:0019503)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| terbufos | increases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Cisplatin | increases expression | 1 |
| Fonofos | increases methylation | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Lead | affects splicing | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Parathion | increases methylation | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Paclitaxel | affects response to substance | 1 |
| 1-Butanol | affects cotreatment, increases abundance, increases expression | 1 |
| Particulate Matter | affects cotreatment, increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KU21 | HeLa SilenciX WDR8 | Cancer cell line | Female |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05641103 | Not specified | COMPLETED | PREDIGA 2: Spanish Acronym of Educational and Diagnostic Project for Gaucher and ASMD |
Related Atlas pages
- Associated diseases: anterior segment dysgenesis
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): anterior segment dysgenesis